Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression

被引:155
|
作者
Agoulnik, IU
Vaid, A
Bingman, WE
Erdeme, H
Frolov, A
Smith, CL
Ayala, G
Ittmann, MM
Weigel, NL
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Urol, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.CAN-04-3541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer is initially androgen dependent and there is evidence that androgen receptor continues to play a role in androgen-independent prostate cancer. Androgen receptor activity depends both on the level of androgens and on the level of coactivators that interact with androgen receptor. Our goal was to evaluate the role of the androgen receptor coactivator SRC-l in prostate cancer progression. Using tissue arrays to measure SRC-I protein levels, we found that increased SRC-1 expression in clinically localized, androgen-dependent cancer is associated with clinical and pathologic variables of increased tumor aggressiveness. Interestingly, there was variable expression of SRC-1 in normal prostate tissue which correlated with the staining intensity of the corresponding cancer tissue. To test the contribution of SRC-1, we examined its role in androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer cell lines. Using small interfering RNA to reduce expression of androgen receptor, we found that androgen receptor was required both for cell growth and for basal expression of prostate-specific antigen in the androgen-independent C4-2 cell line. Thus, although the cells can grow in an androgen-depleted medium, they remained androgen receptor dependent. Reduction of SRC-1 expression significantly reduced growth and altered androgen receptor target gene regulation in both LNCaP and C4-2 cell lines whereas it had no effect on the growth of the androgen receptor-negative PC-3 and DU145 prostate cancer cell lines. Although the requirement for androgens and androgen receptor in the development of prostate cancer is well established, our study implicates enhanced androgen receptor activity through elevated expression of SRC-I in the development of more aggressive disease in men with prostate cancer.
引用
收藏
页码:7959 / 7967
页数:9
相关论文
共 50 条
  • [21] Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation
    Wang, Shu
    Yuan, Yuhui
    Liao, Lan
    Kuang, Shao-Qing
    Tien, Jean
    O'Malley, Bert
    Xu, Jianming
    CANCER RESEARCH, 2009, 69
  • [22] Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1
    McBryan, Jean
    Theissen, Sarah M.
    Byrne, Christopher
    Hughes, Eamon
    Cocchiglia, Sinead
    Sande, Stephen
    O'Hara, Jane
    Tibbitts, Paul
    Hill, Arnold D. K.
    Young, Leonie S.
    CANCER RESEARCH, 2012, 72 (02) : 548 - 559
  • [23] Role for the Werner syndrome protein in the promotion of tumor cell growth
    Opresko, Patricia L.
    Calvo, Jose Palacios
    von Kobbe, Cayetano
    MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (7-8) : 423 - 436
  • [24] Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation
    Wang, Shu
    Yuan, Yuhui
    Liao, Lan
    Kuang, Shao-Qing
    Tien, Jean Ching-Yi
    O'Malley, Bert W.
    Xu, Jianming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) : 151 - 156
  • [25] SRC-1 Promotes Disease Progression in Endocrine Treatment-Resistant Breast Cancer by Silencing Tumour Suppressor Genes
    Ward, E.
    Vareslija, D.
    Fagan, A.
    Hill, A. D. K.
    Young, L.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S349 - S349
  • [26] Estradiol increases cell growth in human astrocytoma cell lines through ERα activation and its interaction with SRC-1 and SRC-3 coactivators
    Gonzalez-Arenas, Aliesha
    Hansberg-Pastor, Valeria
    Tania Hernandez-Hernandez, Olivia
    Karina Gonzalez-Garcia, Tania
    Henderson-Villalpando, Joshua
    Lemus-Hernandez, Diana
    Cruz-Barrios, Aglae
    Rivas-Suarez, Mariana
    Camacho-Arroyo, Ignacio
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (02): : 379 - 386
  • [28] Global transcription factor repression by the coactivator SRC-1 mediates disease progression in endocrine-resistant breast cancer
    Vareslija, Damir
    Ward, Elspeth
    Fagan, Allis
    Gallagher, William
    Hill, Arnold D. K.
    Young, Leonie S.
    CANCER RESEARCH, 2016, 76
  • [29] Modulation of Cancer Cell Growth and Progression by Caveolin-1 in the Tumor Microenvironment
    Yoon, Hyo-Jin
    Surh, Young-Joon
    TUMOR MICROENVIRONMENT: MOLECULAR PLAYERS, PT B, 2020, 1277 : 63 - 74
  • [30] THE ROLE OF PARP2 IN PROSTATE CANCER GROWTH AND PROGRESSION
    Gui, Bin
    Kibel, Adam
    Jia, Li
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1150 - E1151